Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07.
Kim M, Keam B, Ock CY, Kim SH, Kim YJ, Lim SM, Kim JS, Kim TM, Hong SH, Ahn MS, Shin SH, Kang EJ, Kim DW, Im SW, Kim JI, Lee JS, Kim JH, Heo DS.
Kim M, et al. Among authors: kim ji, kim yj, kim dw, kim sh, kim js, kim tm, kim jh.
Thorac Cancer. 2020 Dec;11(12):3482-3489. doi: 10.1111/1759-7714.13684. Epub 2020 Oct 7.
Thorac Cancer. 2020.
PMID: 33026712
Free PMC article.
Clinical Trial.